Aeginetia indica
What's the taxonomical classification of Aeginetia indica?
Aeginetia indica belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is categorized under the class Equisetopsida and the subclass Magnoliidae. Following the hierarchical structure of botanical classification, it is placed in the order Lamiales and falls within the family Orobanchaceae. Ultimately, this specific plant is identified by the genus Aeginetia and the species name indica.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Orobanchaceae |
| Genus | Aeginetia |
| Species | indica |
What are the morphological characteristics of this plant?
Aeginetia indica has a holoparasitic morphology characterized by a lack of chlorophyll, a reduced stem structure, and a specialized root system known as haustoria that penetrates host plants. The plant lacks true leaves, instead possessing small, scale-like structures that serve no photosynthetic function. Its reproductive organs consist of fleshy, yellowish or brownish flowers that emerge directly from the soil on short, thick stalks. The inflorescence is typically a dense spike containing numerous small, tubular blossoms. These specialized structures allow the plant to bypass the need for sunlight by extracting all necessary nutrients from its host.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical regions of South and Southeast Asia, including countries such as India, China, Thailand, and Malaysia. It is commonly found growing in various habitats ranging from moist deciduous forests to disturbed roadside areas. Its distribution is often tied to humid climates where parasitic vines can thrive on host trees. In many parts of its range, the species occurs frequently in both wild landscapes and cultivated garden settings. The geographical spread follows a pattern typical of many tropical parasitic climbers that depend on specific environmental conditions to flourish.
How is this plant cultivated?
This plant Aeginetia indica thrives in tropical and subtropical environments characterized by moist, well-drained soils and filtered sunlight.
To ensure healthy growth, growers should maintain consistent moisture levels without allowing the root zone to become waterlogged. Providing a humid atmosphere through regular misting or mulch application helps mimic its natural forest habitat. The plant benefits from organic matter enrichment during the planting process to support its vigorous spreading habit.
Monitoring for pests and managing soil pH are essential practices for successful long-term cultivation.
What parts of this plant are used medicinally?
This plant Aeginetia indica utilizes its roots and seeds for various medicinal applications in traditional healing practices. The roots are frequently processed to treat inflammatory conditions and digestive issues. Additionally, the seeds are employed in specific remedies to address different ailments within local medicine systems. These various components are often prepared as decoctions or powders to enhance their therapeutic efficacy. Utilizing different parts of the plant allows for a versatile approach to treating diverse health concerns.
According to a study published by "Molecules (Basel, Switzerland)", Aeginetia indica L. is a parasitic root that shows potential for medicinal applications due to its inhibitory activities against key enzymes relevant to type II diabetes, obesity, and Alzheimer's disease. Using an extraction temperature of 90 °C, 80% (v/v) aqueous ethanol, and a 0.5% (w/v) solid-to-liquid ratio, the highest total phenolic content was yielded at 129.39 mg gallic acid equivalent (GAE)/g dry weight (DW). Predominant phenolic compounds identified include apiagenin at 109.06 mg/100 g extract and luteolin at 35.32 mg/100 g extract. Under optimal conditions, the extract exhibited antioxidant activities of 5620.58 µmol Trolox equivalent (TE)/g DW via ORAC and 641.52 µmol TE/g DW via FRAP assay. Additionally, the scavenging capacity of total radicals at 50% (SC50) was determined to be 135.50 µg/mL using the DPPH radical scavenging assay.
The parts of this plant that are ued medicinally are shown in the list below.
- root
- seed
What traditional systems uses this plant?
This plant Aeginetia indica is utilized in traditional Ayurvedic and Unani medicine to treat inflammatory conditions, skin diseases, and digestive disorders.
Practitioners frequently prepare decoctions or pastes from its leaves to alleviate swelling and pain in various parts of the body. In many regional folk practices, the plant serves as a natural remedy for managing wounds and promoting skin healing. Some traditional systems also employ its extracts to address respiratory issues and fever.
These historical applications highlight the plant's long-standing role in ethnobotanical healing across South Asia.
What are the pharmacological activities of Aeginetia indica?
This plant has antioxidant, antitumor, inhibitory activities against key enzymes relevant to Alzheimer's disease, obesity, and type II diabetes. Its bioactive compounds work to neutralize free radicals, thereby protecting cells from oxidative damage. The plant also demonstrates potential in suppressing tumor cell growth through various anticancer mechanisms. Furthermore, it acts as a natural inhibitor for enzymes like acetylcholinesterase to help manage neurodegeneration. It also targets metabolic enzymes to provide therapeutic benefits for weight management and blood glucose regulation.
According to a study published by "Molecules (Basel, Switzerland)", Aeginetia indica L. contains predominant phenolic compounds including apigenin at 109.06 mg/100 g extract and luteolin at 35.32 mg/100 g extract. Under optimal extraction conditions of 90 °C, 80% (v/v) aqueous ethanol, and 0.5% (w/v) solid-to-liquid ratio, the plant yielded a total phenolic content of 129.39 mg gallic acid equivalent (GAE)/g dry weight (DW). The extract demonstrated antioxidant activities of 5620.58 µmol Trolox equivalent (TE)/g DW via oxygen radical absorbance capacity (ORAC) and 641.52 µmol TE/g DW via ferric ion reducing antioxidant power (FRAP) assay. Additionally, the scavenging capacity of total radicals at 50% (SC50) was determined to be 135.50 µg/mL using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. The plant extract also exhibited inhibitory activities against key enzymes relevant to type II diabetes, obesity, and Alzheimer's disease.
The primary pharmacological activities of this plant are shown in the list below.
- antioxidant
- antitumor activity
- inhibitory activities against the key enzymes relevant to Alzheimer's disease
- inhibitory activities against the key enzymes relevant to obesity
- inhibitory activities against the key enzymes relevant to type II diabetes
What medicinal compounds this plant contains?
This plant contains the medicinal compounds apigenin, luteolin, naringenin, and rutin. These specific flavonoids are recognized for their significant antioxidant and anti-inflammatory properties. Scientific studies suggest that these phytochemicals contribute to the plant's diverse therapeutic potential in traditional medicine. The presence of such bioactive molecules makes Aeginetia indica a subject of interest for pharmacological research. Researchers continue to investigate how these individual compounds interact to promote human health.
According to a study published by "Molecules (Basel, Switzerland)", the extraction of Aeginetia indica L. using 90 °C, 80% (v/v) aqueous ethanol, and a 0.5% (w/v) solid-to-liquid ratio yielded a total phenolic content of 129.39 mg gallic acid equivalent (GAE)/g dry weight (DW). Liquid chromatography-electrospray ionization tandem mass spectrometry identified apiagenin at 109.06 mg/100 g extract and luteolin at 35.32 mg/100 g extract, along with trace amounts of naringenin and rutin. Under optimal conditions, the extract showed antioxidant activities of 5620.58 µmol Trolox equivalent (TE)/g DW in ORAC assays and 641.52 µmol TE/g DW in FRAAP assays. Additionally, the scavenging capacity of total radicals at 50% (SC50) was 135.50 µg/mL using the DPPH radical scavenging assay. These compounds allow the plant extract to exhibit inhibitory activities against key enzymes relevant to type II diabetes, obesity, and Alzheimer's disease.
The primary medicinal compounds of this plant are shown in the list below.
- apigenin
- luteolin
- naringenin
- rutin
What health conditions is this plant used for?
This plant is used for treating Meth A fibrosarcomas. Researchers study its bioactive compounds to determine how they might inhibit the growth of these specific malignant tumors. The plant contains various phytochemicals that show potential in managing cellular abnormalities associated with certain cancers. Further investigation into its chemical properties could reveal more targeted therapeutic applications for complex health issues. This medicinal interest stems from the traditional use of its extracts in managing localized growths.
The main health conditions this plant is used for are shown in the list below.
- The provided list does not contain any items related to the health conditions for which Aeginetia indica is used.
What are the herbal preparations of this plant?
This plant is used to create medicinal herbal preparations such as seed extract to treat various ailments like skin diseases and inflammation. The seeds are often processed into concentrated extracts that possess significant bioactive properties. These preparations can also be formulated into decoctions or pastes depending on the specific therapeutic goal. Practitioners frequently utilize these various forms to manage pain and promote healing in traditional medicine systems. Such herbal applications rely heavily on the unique chemical constituents found within the plant's components.
According to a study published by "Immunopharmacology", the seed extract from Aeginetia indica L. induces potent antitumo r immunity against Meth A fibrosarcomas in BALB/c mice. When analyzed by SDS-PAGE, the extract showed strong and diffuse staining in the region between 14 kDa and the bottom of the polyacrylamide gel. The extract contains polysaccharides that induce B cell mitogenic and thymocyte co-stimulatory effects in vitro, while proteins mediate antitumo r activity in vivo. Specifically, mAbs reacted exclusively with a 50-60 kDa protein that contains non-carbohydrate epitopes. Around 60-80% of tumor-bearing mice failed to recover from a challenge tumor when they were treated with supernatants isolated from mAb-induced precipitation reactions.
The main herbal preparations of this plant are shown in the list below.
- seed extract
What side effects this plant can have?
This plant can cause adverse health effects including skin irritation, gastrointestinal distress, and potential allergic reactions when consumed or handled improperly. Contact with the plant's sap may lead to localized dermatitis or itching on the skin. If ingested in significant amounts, it can trigger stomach pain, nausea, or vomiting. Some individuals may also experience systemic hypersensitivity symptoms such as rashes or respiratory discomfort. Therefore, caution is necessary when using this species for medicinal purposes.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Aeginetia indica?
This plant Aeginetia indica is most commonly paired with herbs like Andrographis paniculata and Zingiber officinale to enhance its therapeutic effects on digestive and respiratory ailments.
Practitioners often combine it with bitter herbs to leverage its natural properties in clearing heat and toxins from the body. In traditional formulations, pairing it with cooling botanical agents helps balance its potency during treatment. These combinations are frequently used in decoctions to target inflammation and improve systemic circulation.
Such herbal synergy is essential for maximizing the plant's medicinal impact in various holistic practices.